1. Home
  2. XRTX vs CREG Comparison

XRTX vs CREG Comparison

Compare XRTX & CREG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XRTX
  • CREG
  • Stock Information
  • Founded
  • XRTX 2011
  • CREG N/A
  • Country
  • XRTX Canada
  • CREG China
  • Employees
  • XRTX N/A
  • CREG N/A
  • Industry
  • XRTX Pharmaceuticals and Biotechnology
  • CREG Power Generation
  • Sector
  • XRTX Health Care
  • CREG Utilities
  • Exchange
  • XRTX Nasdaq
  • CREG Nasdaq
  • Market Cap
  • XRTX 3.4M
  • CREG 3.5M
  • IPO Year
  • XRTX N/A
  • CREG N/A
  • Fundamental
  • Price
  • XRTX $0.84
  • CREG $1.45
  • Analyst Decision
  • XRTX
  • CREG
  • Analyst Count
  • XRTX 0
  • CREG 0
  • Target Price
  • XRTX N/A
  • CREG N/A
  • AVG Volume (30 Days)
  • XRTX 104.3K
  • CREG 4.5M
  • Earning Date
  • XRTX 08-15-2025
  • CREG 08-14-2025
  • Dividend Yield
  • XRTX N/A
  • CREG N/A
  • EPS Growth
  • XRTX N/A
  • CREG N/A
  • EPS
  • XRTX N/A
  • CREG N/A
  • Revenue
  • XRTX N/A
  • CREG $82,839.00
  • Revenue This Year
  • XRTX N/A
  • CREG N/A
  • Revenue Next Year
  • XRTX N/A
  • CREG N/A
  • P/E Ratio
  • XRTX N/A
  • CREG N/A
  • Revenue Growth
  • XRTX N/A
  • CREG N/A
  • 52 Week Low
  • XRTX $0.66
  • CREG $1.11
  • 52 Week High
  • XRTX $2.98
  • CREG $14.70
  • Technical
  • Relative Strength Index (RSI)
  • XRTX 51.88
  • CREG 40.02
  • Support Level
  • XRTX $0.70
  • CREG $1.11
  • Resistance Level
  • XRTX $0.87
  • CREG $1.52
  • Average True Range (ATR)
  • XRTX 0.07
  • CREG 0.25
  • MACD
  • XRTX 0.00
  • CREG 0.06
  • Stochastic Oscillator
  • XRTX 60.87
  • CREG 22.67

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

About CREG Smart Powerr Corp.

Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company offers waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.

Share on Social Networks: